[Special Stock] 'Kolon TissueGene' Trading Resumption Effect?... ShillaJen Also Surges 10%

On the 13th, when SillaJen resumed trading after 2 years and 5 months, the SillaJen stock price was displayed on the market board at the Korea Exchange in Yeouido, Seoul. Photo by Jinhyung Kang aymsdream@

[Asia Economy Reporter Ji Yeon-jin] ShillaJen surged more than 10% on the 25th, riding the strong performance of biotech stocks.

At 9:22 a.m. on the same day, ShillaJen was trading at 13,000 won on the KOSDAQ market, up 11.54% (1,300 won) compared to the previous day.

This is interpreted as an effect of Kolon TissueGene resuming trading for the first time in 3 years and 5 months and immediately hitting the upper price limit. ShillaJen's stock trading was suspended in May 2020 due to allegations of embezzlement and breach of trust by management, and trading resumed on the 13th of this month. At that time, ShillaJen recorded the upper price limit for two consecutive days. After showing a recent downturn, it surged again on this day.